eLife (Oct 2018)

INAVA-ARNO complexes bridge mucosal barrier function with inflammatory signaling

  • Phi Luong,
  • Matija Hedl,
  • Jie Yan,
  • Tao Zuo,
  • Tian-Min Fu,
  • Xiaomo Jiang,
  • Jay R Thiagarajah,
  • Steen H Hansen,
  • Cammie F Lesser,
  • Hao Wu,
  • Clara Abraham,
  • Wayne I Lencer

DOI
https://doi.org/10.7554/eLife.38539
Journal volume & issue
Vol. 7

Abstract

Read online

Homeostasis at mucosal surfaces requires cross-talk between the environment and barrier epithelial cells. Disruption of barrier function typifies mucosal disease. Here we elucidate a bifunctional role in coordinating this cross-talk for the inflammatory bowel disease risk-gene INAVA. Both activities require INAVA’s DUF3338 domain (renamed CUPID). CUPID stably binds the cytohesin ARF-GEF ARNO to effect lateral membrane F-actin assembly underlying cell-cell junctions and barrier function. Unexpectedly, when bound to CUPID, ARNO affects F-actin dynamics in the absence of its canonical activity as a guanine nucleotide-exchange factor. Upon exposure to IL-1β, INAVA relocates to form cytosolic puncta, where CUPID amplifies TRAF6-dependent polyubiquitination and inflammatory signaling. In this case, ARNO binding to CUPID negatively-regulates polyubiquitination and the inflammatory response. INAVA and ARNO act similarly in primary human macrophages responding to IL-1β and to NOD2 agonists. Thus, INAVA-CUPID exhibits dual functions, coordinated directly by ARNO, that bridge epithelial barrier function with extracellular signals and inflammation.

Keywords